• Agency News

Donna LaVoie Featured in Life Sciences Global Business Report on the Regulatory Landscape


Donna LaVoie, LaVoieHealthScience CEO and President, was featured in Global Business Report’s United States Life Sciences 2023. In the article, “The Regulatory Landscape: Measuring the Inflation Reduction Act Implications,” Donna is quoted saying:

โ€œThe Inflation Reduction Act is a big deal. Drug approvals and pricing is top of mind and heading news lines. We are currently in an environment where the investors will want to understand the regulatory environment and reimbursement before investing.โ€

Download the PDF here. Read the digital interactive version here.

Share This Post